TP53 and cancer: Ser31 of H3.3 can be phosphorylated by the DNA damage response kinase CHK-1 in cancer cells that rely on the alternative lengthening of telomeres (ALT) pathway (Chang et al. 2015), although in the aforementioned study p53 activation from H3.3.